| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010832 |
| Receipt No. | R000012613 |
| Official scientific title of the study | Study to elucidate the incidence of SSA/P in serrated lesions of the colorectum |
| Date of disclosure of the study information | 2013/06/01 |
| Last modified on | 2016/04/13 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Study to elucidate the incidence of SSA/P in serrated lesions of the colorectum | |
| Title of the study (Brief title) | SSA/P Study | |
| Region |
|
|
| Condition | ||
| Condition | SSA/P | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate the incidence of SSA/P in serrated lesions of the colorectum. |
| Basic objectives2 | Others |
| Basic objectives -Others | To elucidate the incidence of SSA/P in serrated lesions of the colorectum. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The incidence of SSA/P in serrated lesions of the colorectum. |
| Key secondary outcomes | Macroscopic features and malignant potential of SSA/P. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients aged 40 and over | |||
| Key exclusion criteria | Patients with a history of polypectomy for colorectal serrated polyps.
Patients with a history of colectomy or rectectomy. Patients with inflammatory bowel disease. Patients with a family history of colorectal polyposis or HNPCC. Patients with colorectal polyposis or HNPCC. |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Wataru Sano |
| Organization | Sano hospital |
| Division name | Institute of Minimally-invasive Endoscopic Care (iMEC) |
| Address | 2-5-1, Shimizugaoka, Tarumi, Kobe, Hyogo, Japan |
| TEL | 078-785-1000 |
| watasano@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Wataru Sano |
| Organization | Sano hospital |
| Division name | Institute of Minimally-invasive Endoscopic Care (iMEC) |
| Address | 2-5-1, Shimizugaoka, Tarumi, Kobe, Hyogo, Japan |
| TEL | 078-785-1000 |
| Homepage URL | |
| watasano@yahoo.co.jp | |
| Sponsor | |
| Institute | Sano hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 佐野病院(兵庫県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0034-1391948 |
| Results | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012613 |